PG Form 144 filed: 725 shares planned for sale on Oct 30, 2025

Rhea-AI Filing Summary

The Procter & Gamble Company: a stockholder filed a Form 144 for a proposed sale of 725 shares of common stock with an aggregate market value of $110,123.88. The approximate sale date is October 30, 2025, to be executed on the NYSE through Morgan Stanley Smith Barney LLC.

The filer reported acquiring 1,044 shares on August 18, 2025 via a Performance Stock Program Award. In the past three months, the filer reported a sale of 319 shares on August 19, 2025 for $50,170.34 in gross proceeds.

Shares outstanding were 2,336,733,549; this is a baseline figure, not the amount being offered.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	725	110123.88	2336733549	10/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			1044	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew W. Janzaruk One Procter & Gamble Plaza Cincinnati OH 45202	Common Stock	08/19/2025	319	50170.34

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did PG (Procter & Gamble) disclose in this Form 144?

A proposed sale of 725 common shares with an aggregate market value of $110,123.88.

When is the proposed sale date for PG shares?

The approximate sale date is October 30, 2025.

Which broker and exchange are indicated for the PG share sale?

Broker: Morgan Stanley Smith Barney LLC; Exchange: NYSE.

How were the PG shares being sold acquired?

The filer acquired 1,044 shares on August 18, 2025 via a Performance Stock Program Award.

Were any PG shares sold in the prior three months?

Yes. 319 shares were sold on August 19, 2025 for $50,170.34 in gross proceeds.

How many PG shares are outstanding?

Shares outstanding were reported as 2,336,733,549.

What class of PG securities is involved?

The filing pertains to Common Stock.